Managing Survivorship – Stage 4 and Metastatic-Castration Resistant Prostate Cancer

PHEN reviews Treatment Options for Stage 4 and Metastatic Castration Resistant Prostate Cancer (mCRPC) using PHENPath.com

 

Presented by:

James Smith, III, MD

PHEN Ambassador Member

Leave a Reply

Your email address will not be published. Required fields are marked *